Head-to-head · Cost-Efficiency Index
Society of You vs VyrarX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Society of You
Shoppers open to completing an eligibility quiz before seeing any price, since none is public.
Visit Society of YouVyrarX
Shoppers comparing headline GLP-1 starting prices who don't need pharmacy/clinical-leadership transparency up front.
Visit VyrarXThe verdict
Society of You and VyrarX tie on the Cost-Efficiency Index at 49/100, so neither wins outright on the numbers. For most shoppers we'd start with Society of You (ranked #425, a hair above #428) — Shoppers open to completing an eligibility quiz before seeing any price, since none is public. But VyrarX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Society of You.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Society of You | VyrarX |
|---|---|---|
| Cost-Efficiency Index | 49/100 | 49/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #425 | #428 |
Society of You
49/100Where the value is
- Offers both compounded and branded GLP-1 options (Ozempic/Wegovy/Mounjaro) plus microdosing
- Part of a broader longevity/performance platform with sexual health and skin/hair verticals
- Mobile apps available on iOS and Android
The tradeoffs
- No public pricing page -- the linked /pricing URL 404s, so cost is fully gated behind signup
- No named medical director found in reachable content
VyrarX
49/100Where the value is
- Clear headline pricing for both semaglutide and tirzepatide
- Claims broad 47-state coverage
- LegitScript seal displayed on the homepage
The tradeoffs
- No named medical director or clinical leadership anywhere on the public site
- No named compounding pharmacy partner disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.